Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Jansen van Vuren, Petrus ^a,b   Tiemessen, Caroline T ^a,b   Paweska, Janusz T ^a,b  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; BETA INTERFERON; GAMMA INTERFERON; INTERFERON; RECOMBINANT NUCLEOCAPSID PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; NUCLEOCAPSID PROTEIN; VIRUS DNA; VIRUS VACCINE;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B LYMPHOCYTE ACTIVATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE EXPRESSION REGULATION; HEPATITIS; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INFLAMMATION; INNATE IMMUNITY; MOUSE; NONHUMAN; RIFT VALLEY FEVER; RIFT VALLEY FEVER BUNYAVIRUS; SPLEEN; T LYMPHOCYTE ACTIVATION; VIRUS LOAD; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; GENETICS; IMMUNOLOGY; LIVER; PATHOGENICITY; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; VACCINATION; VIRION; VIROLOGY; VIRUS NUCLEOCAPSID; VIRUS REPLICATION;

ANIMALIA; MUS; RIFT VALLEY FEVER VIRUS;

ANIMALS; DNA, VIRAL; FEMALE; IMMUNITY, CELLULAR; IMMUNIZATION; LIVER; MICE; MICE, INBRED BALB C; NUCLEOCAPSID; NUCLEOCAPSID PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RIFT VALLEY FEVER; RIFT VALLEY FEVER VIRUS; SPLEEN; T-LYMPHOCYTES; VACCINATION; VIRAL VACCINES; VIRION; VIRUS REPLICATION;

EID: 80052834815     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025027     Document Type: Article

References (107)

1. Woods CW, Karpati AM, Grein T, McCarthy N, Gaturuku P, et al. (2002) An outbreak of Rift Valley fever in Northeastern Kenya, 1997-98. Emerg Infect Dis 8: 138-144.
2. Swanepoel R, Coetzer JAW, (2004) Rift Valley fever. In: Coetzer JAW, Tustin RC, editors. Infectious Diseases of Livestock Cape Town Oxford University Press pp. 1037-1070.
3. Rich KM, Wanyoike F, (2010) An assessment of the regional and national socio-economic impacts of the 2007 Rift Valley fever outbreak in Kenya. Am J Trop Med Hyg 83: 52-57.
4. Giorgi C, Accardi L, Nicoletti L, Gro MC, Takehara K, et al. (1991) Sequences and coding strategies of the S RNAs of Toscana and Rift Valley fever viruses compared to those of Punta Toro, Sicilian Sandfly fever, and Uukuniemi viruses. Virology 180: 738-753.
5. Ihara T, Smith J, Dalrymple JM, Bishop DH, (1985) Complete sequences of the glycoproteins and M RNA of Punta Toro phlebovirus compared to those of Rift Valley fever virus. Virology 144: 246-259.
6. Magurano F, Nicoletti L, (1999) Humoral response in Toscana virus acute neurologic disease investigated by viral-protein-specific immunoassays. Clin Diagn Lab Immunol 6: 55-60.
7. Swanepoel R, Struthers JK, Erasmus MJ, Shepherd SP, McGillivray GM, et al. (1986) Comparative pathogenicity and antigenic cross-reactivity of Rift Valley fever and other African phleboviruses in sheep. J Hyg (Lond) 97: 331-346.
8. Vapalahti O, Kallio-Kokko H, Narvanen A, Julkunen I, Lundkvist A, et al. (1995) Human B-cell epitopes of Puumala virus nucleocapsid protein, the major antigen in early serological response. Journal of Medical Virology 46: 293-303.
9. Fafetine JM, Tijhaar E, Paweska JT, Neves LC, Hendriks J, et al. (2007) Cloning and expression of Rift Valley fever virus nucleocapsid (N) protein and evaluation of a N-protein based indirect ELISA for the detection of specific IgG and IgM antibodies in domestic ruminants. Vet Microbiol 121: 29-38.
10. Jansen van Vuren P, Potgieter AC, Paweska JT, van Dijk AA, (2007) Preparation and evaluation of a recombinant Rift Valley fever virus N protein for the detection of IgG and IgM antibodies in humans and animals by indirect ELISA. J Virol Methods 140: 106-114.
11. Gauliard N, Billecocq A, Flick R, Bouloy M, (2006) Rift Valley fever virus noncoding regions of L, M and S segments regulate RNA synthesis. Virology 351: 170-179.
12. Lorenzo G, Martin-Folgar R, Rodriguez F, Brun A, (2008) Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep. Vaccine 26: 5255-5262.
13. Liu L, Celma CC, Roy P, (2008) Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins. Virol J 5: 82.
14. Lorenzo G, Martin-Folgar R, Hevia E, Boshra H, Brun A, (2010) Protection against lethal Rift Valley fever virus (RVFV) infection in transgenic IFNAR(-/-) mice induced by different DNA vaccination regimens. Vaccine 28: 2937-2944.
15. Lagerqvist N, Naslund J, Lundkvist A, Bouloy M, Ahlm C, et al. (2009) Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs. Virol J 6: 6.
16. Wallace DB, Ellis CE, Espach A, Smith SJ, Greyling RR, et al. (2006) Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever. Vaccine 24: 7181-7189.
17. Jansen van Vuren P, Tiemessen CT, Paweska JT, (2010) Evaluation of a recombinant Rift Valley fever virus subunit nucleocapsid protein as an immunogen in mice and sheep. The Open Vaccine Journal 3: 114-126.
18. Heise MT, Whitmore A, Thompson J, Parsons M, Grobbelaar AA, et al. (2009) An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus. Epidemiol Infect 137: 1309-1318.
19. Kortekaas J, de Boer SM, Kant J, Vloet RP, Antonis AF, et al. (2010) Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector. Vaccine 28: 4394-4401.
20. Mandell RB, Koukuntla R, Mogler LJ, Carzoli AK, Freiberg AN, et al. (2010) A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge. Virology 397: 187-198.
21. Morrill JC, Jennings GB, Johnson AJ, Cosgriff TM, Gibbs PH, et al. (1990) Pathogenesis of Rift Valley fever in rhesus monkeys: role of interferon response. Arch Virol 110: 195-212.
22. Sandrock M, Frese M, Haller O, Kochs G, (2001) Interferon-induced rat Mx proteins confer resistance to Rift Valley fever virus and other arthropod-borne viruses. J Interferon Cytokine Res 21: 663-668.
23. Anderson GW Jr, Peters CJ, (1988) Viral determinants of virulence for Rift Valley fever (RVF) in rats. Microb Pathog 5: 241-250.
24. Peters CJ, Jones D, Trotter R, Donaldson J, White J, et al. (1988) Experimental Rift Valley fever in rhesus macaques. Arch Virol 99: 31-44.
25. Le May N, Mansuroglu Z, Leger P, Josse T, Blot G, et al. (2008) A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. PLoS Pathog 4: e13.
26. Bouloy M, Weber F, (2010) Molecular biology of rift valley Fever virus. Open Virol J 4: 8-14.
27. Le May N, Dubaele S, Proietti De Santis L, Billecocq A, Bouloy M, et al. (2004) TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell 116: 541-550.
28. Habjan M, Pichlmair A, Elliott RM, Overby AK, Glatter T, et al. (2009) NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. J Virol 83: 4365-4375.
29. Strauss JH, Strauss EG, (2008) Viruses and Human Disease, 2nd Edition Oxford Elsevier.
30. Morrill JC, Czarniecki CW, Peters CJ, (1991) Recombinant human interferon-gamma modulates Rift Valley fever virus infection in the rhesus monkey. J Interferon Res 11: 297-304.
31. Bouloy M, Janzen C, Vialat P, Khun H, Pavlovic J, et al. (2001) Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs. J Virol 75: 1371-1377.
32. Won S, Ikegami T, Peters CJ, Makino S, (2007) NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis. J Virol 81: 13335-13345.
33. Do Valle TZ, Billecocq A, Guillemot L, Alberts R, Gommet C, et al. (2010) A new mouse model reveals a critical role for host innate immunity in resistance to Rift Valley fever. J Immunol 185: 6146-6156.
34. Mollereau B, Deckert M, Deas O, Rieux-Laucat F, Hirsch F, et al. (1996) CD2-induced apoptosis in activated human peripheral T cells: a Fas-independent pathway that requires early protein tyrosine phosphorylation. J Immunol 156: 3184-3190.
35. Afford SC, Ahmed-Choudhury J, Randhawa S, Russell C, Youster J, et al. (2001) CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signaling in human intrahepatic biliary epithelial cells. Faseb J 15: 2345-2354.
36. Wu MY, Liang YR, Wu XY, Zhuang CX, (2002) Relationship between Egr-1 gene expression and apoptosis in esophageal carcinoma and precancerous lesions. World J Gastroenterol 8: 971-975.
37. Li J, Billiar TR, (1999) Nitric Oxide. IV. Determinants of nitric oxide protection and toxicity in liver. Am J Physiol 276: G1069-1073.
38. Zhao Y, Rangnekar VM, (2008) Apoptosis and tumor resistance conferred by Par-4. Cancer Biol Ther 7: 1867-1874.
39. Hung JH, Lu YS, Wang YC, Ma YH, Wang DS, et al. (2008) FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C delta signaling. Cancer Res 68: 1204-1212.
40. Kiebala M, Polesskaya O, Yao Z, Perry SW, Maggirwar SB, (2010) Nuclear factor-kappa B family member RelB inhibits human immunodeficiency virus-1 Tat-induced tumor necrosis factor-alpha production. PLoS One 5: e11875.
41. Matsui H, Hikichi Y, Tsuji I, Yamada T, Shintani Y, (2002) LIGHT, a member of the tumor necrosis factor ligand superfamily, prevents tumor necrosis factor-alpha-mediated human primary hepatocyte apoptosis, but not Fas-mediated apoptosis. J Biol Chem 277: 50054-50061.
42. Bustelo XR, (2001) Vav proteins, adaptors and cell signaling. Oncogene 20: 6372-6381.
43. Cho SJ, Kang MJ, Homer RJ, Kang HR, Zhang X, et al. (2006) Role of early growth response-1 (Egr-1) in interleukin-13-induced inflammation and remodeling. J Biol Chem 281: 8161-8168.
44. Lomonosova E, Chinnadurai G, (2008) BH3-only proteins in apoptosis and beyond: an overview. Oncogene 27 (Suppl 1): S2-19.
45. Kong M, Fox CJ, Mu J, Solt L, Xu A, et al. (2004) The PP2A-associated protein alpha4 is an essential inhibitor of apoptosis. Science 306: 695-698.
46. Kittipatarin C, Khaled AR, (2007) Interlinking interleukin-7. Cytokine 39: 75-83.
47. Jackson LN, Larson SD, Silva SR, Rychahou PG, Chen LA, et al. (2008) PI3K/Akt activation is critical for early hepatic regeneration after partial hepatectomy. Am J Physiol Gastrointest Liver Physiol 294: G1401-1410.
48. Yu-Lee LY, (2002) Prolactin modulation of immune and inflammatory responses. Recent Prog Horm Res 57: 435-455.
49. Li Y, Zhou Z, Chen C, (2008) WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis. Cell Death Differ 15: 1941-1951.
50. Coleman JW, (2002) Nitric oxide: a regulator of mast cell activation and mast cell-mediated inflammation. Clin Exp Immunol 129: 4-10.
51. Peters AL, Stunz LL, Bishop GA, (2009) CD40 and autoimmunity: the dark side of a great activator. Semin Immunol 21: 293-300.
52. Senaldi G, Varnum BC, Sarmiento U, Starnes C, Lile J, et al. (1999) Novel neurotrophin-1/B cell-stimulating factor-3: a cytokine of the IL-6 family. Proc Natl Acad Sci U S A 96: 11458-11463.
53. Dalakas E, Newsome PN, Harrison DJ, Plevris JN, (2005) Hematopoietic stem cell trafficking in liver injury. Faseb J 19: 1225-1231.
54. Curnow SJ, Wloka K, Faint JM, Amft N, Cheung CM, et al. (2004) Topical glucocorticoid therapy directly induces up-regulation of functional CXCR4 on primed T lymphocytes in the aqueous humor of patients with uveitis. J Immunol 172: 7154-7161.
55. Lee CG, Hartl D, Matsuura H, Dunlop FM, Scotney PD, et al. (2008) Endogenous IL-11 signaling is essential in Th2- and IL-13-induced inflammation and mucus production. Am J Respir Cell Mol Biol 39: 739-746.
56. Zhou L, Nazarian AA, Smale ST, (2004) Interleukin-10 inhibits interleukin-12 p40 gene transcription by targeting a late event in the activation pathway. Mol Cell Biol 24: 2385-2396.
57. Guo CJ, Atochina-Vasserman EN, Abramova E, Foley JP, Zaman A, et al. (2008) S-nitrosylation of surfactant protein-D controls inflammatory function. PLoS Biol 6: e266.
58. Mazzali M, Kipari T, Ophascharoensuk V, Wesson JA, Johnson R, et al. (2002) Osteopontin-a molecule for all seasons. Qjm 95: 3-13.
59. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS, (2001) Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 107: 1055-1061.
60. Gartel AL, Radhakrishnan SK, (2005) Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res 65: 3980-3985.
61. Lowenstein CJ, Padalko E, (2004) iNOS (NOS2) at a glance. J Cell Sci 117: 2865-2867.
62. Norsworthy PJ, Fossati-Jimack L, Cortes-Hernandez J, Taylor PR, Bygrave AE, et al. (2004) Murine CD93 (C1qRp) contributes to the removal of apoptotic cells in vivo but is not required for C1q-mediated enhancement of phagocytosis. J Immunol 172: 3406-3414.
63. Miletic AV, Graham DB, Sakata-Sogawa K, Hiroshima M, Hamann MJ, et al. (2009) Vav links the T cell antigen receptor to the actin cytoskeleton and T cell activation independently of intrinsic Guanine nucleotide exchange activity. PLoS One 4: e6599.
64. Li J, Nishizawa K, An W, Hussey RE, Lialios FE, et al. (1998) A cdc15-like adaptor protein (CD2BP1) interacts with the CD2 cytoplasmic domain and regulates CD2-triggered adhesion. Embo J 17: 7320-7336.
65. Kunisaki Y, Tanaka Y, Sanui T, Inayoshi A, Noda M, et al. (2006) DOCK2 is required in T cell precursors for development of Valpha14 NK T cells. J Immunol 176: 4640-4645.
66. Zhu R, Diem S, Araujo LM, Aumeunier A, Denizeau J, et al. (2007) The Pro-Th1 cytokine IL-12 enhances IL-4 production by invariant NKT cells: relevance for T cell-mediated hepatitis. J Immunol 178: 5435-5442.
67. Qiao G, Lei M, Li Z, Sun Y, Minto A, et al. (2007) Negative regulation of CD40-mediated B cell responses by E3 ubiquitin ligase Casitas-B-lineage lymphoma protein-B. J Immunol 179: 4473-4479.
68. Qiao G, Li Z, Molinero L, Alegre ML, Ying H, et al. (2008) T-cell receptor-induced NF-kappaB activation is negatively regulated by E3 ubiquitin ligase Cbl-b. Mol Cell Biol 28: 2470-2480.
69. Duttagupta PA, Boesteanu AC, Katsikis PD, (2009) Costimulation signals for memory CD8+ T cells during viral infections. Crit Rev Immunol 29: 469-486.
70. Boesteanu AC, Katsikis PD, (2009) Memory T cells need CD28 costimulation to remember. Semin Immunol 21: 69-77.
71. Ceredig R, Rauch M, Balciunaite G, Rolink AG, (2006) Increasing Flt3L availability alters composition of a novel bone marrow lymphoid progenitor compartment. Blood 108: 1216-1222.
72. Kasler HG, Verdin E, (2007) Histone deacetylase 7 functions as a key regulator of genes involved in both positive and negative selection of thymocytes. Mol Cell Biol 27: 5184-5200.
73. Couper KN, Blount DG, Riley EM, (2008) IL-10: the master regulator of immunity to infection. J Immunol 180: 5771-5777.
74. Khan WN, (2009) B cell receptor and BAFF receptor signaling regulation of B cell homeostasis. J Immunol 183: 3561-3567.
75. Durand CA, Hartvigsen K, Fogelstrand L, Kim S, Iritani S, et al. (2009) Phosphoinositide 3-kinase p110 delta regulates natural antibody production, marginal zone and B-1 B cell function, and autoantibody responses. J Immunol 183: 5673-5684.
76. Kasmar A, Van Rhijn I, Moody DB, (2009) The evolved functions of CD1 during infection. Curr Opin Immunol 21: 397-403.
77. Renukaradhya GJ, Webb TJ, Khan MA, Lin YL, Du W, et al. (2005) Virus-induced inhibition of CD1d1-mediated antigen presentation: reciprocal regulation by p38 and ERK. J Immunol 175: 4301-4308.
78. Palmer MJ, Mahajan VS, Trajman LC, Irvine DJ, Lauffenburger DA, et al. (2008) Interleukin-7 receptor signaling network: an integrated systems perspective. Cell Mol Immunol 5: 79-89.
79. LeVine AM, Whitsett JA, Hartshorn KL, Crouch EC, Korfhagen TR, (2001) Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J Immunol 167: 5868-5873.
80. Zhang R, Zhang N, Mueller DL, (2008) Casitas B-lineage lymphoma b inhibits antigen recognition and slows cell cycle progression at late times during CD4+ T cell clonal expansion. J Immunol 181: 5331-5339.
81. Gracie JA, Robertson SE, McInnes IB, (2003) Interleukin-18. J Leukoc Biol 73: 213-224.
82. Seki Y, Hayashi K, Matsumoto A, Seki N, Tsukada J, et al. (2002) Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation. Proc Natl Acad Sci U S A 99: 13003-13008.
83. Meroni L, Milazzo L, Menzaghi B, Mazzucchelli R, Mologni D, et al. (2007) Altered expression of the tetraspanin CD81 on B and T lymphocytes during HIV-1 infection. Clin Exp Immunol 147: 53-59.
84. Mavoungou E, Bouyou-Akotet MK, Kremsner PG, (2005) Effects of prolactin and cortisol on natural killer (NK) cell surface expression and function of human natural cytotoxicity receptors (NKp46, NKp44 and NKp30). Clin Exp Immunol 139: 287-296.
85. O'Connor GM, Hart OM, Gardiner CM, (2006) Putting the natural killer cell in its place. Immunology 117: 1-10.
86. Janssens S, Beyaert R, (2003) Role of Toll-like receptors in pathogen recognition. Clin Microbiol Rev 16: 637-646.
87. Gibbings D, Befus AD, (2009) CD4 and CD8: an inside-out coreceptor model for innate immune cells. J Leuk Biol 86: 251-259.
88. Billecocq A, Spiegel M, Vialat P, Kohl A, Weber F, et al. (2004) NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J Virol 78: 9798-9806.
89. Pepin M, Bouloy M, Bird BH, Kemp A, Paweska J, (2010) Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Vet Res 41: 61.
90. LaMere MW, Lam H, Moquin A, Haynes L, Lund FE, Randall TD, Kaminski DA, (2011) Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus. J Immunol 186: 4331-4339.
91. Haller O, Weber F, (2009) The interferon response circuit in antiviral host defense. Verh K Acad Geneeskd Belg 71: 73-86.
92. Bai F, Town T, Qian F, Wang P, Kamanaka M, et al. (2009) IL-10 signaling blockade controls murine West Nile virus infection. PLoS Pathog 5: e1000610.
93. Ubol S, Phuklia W, Kalayanarooj S, Modhiran N, (2010) Mechanisms of immune evasion induced by a complex of dengue virus and preexisting enhancing antibodies. J Infect Dis 201: 923-935.
94. Hsu DH, de Waal Malefyt R, Fiorentino DF, Dang MN, Vieira P, et al. (1990) Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 250: 830-832.
95. van Putten SM, Wubben M, Hennink WE, van Luyn MJ, Harmsen MC, (2009) The downmodulation of the foreign body reaction by cytomegalovirus encoded interleukin-10. Biomaterials 30: 730-735.
96. Spencer CI, Barsotti RJ, Berlin JR, (2000) Loading of calcium and strontium into the sarcoplasmic reticulum in rat ventricular muscle. J Mol Cell Cardiol 32: 1285-1300.
97. Gold JA, Parsey M, Hoshino Y, Hoshino S, Nolan A, et al. (2003) CD40 contributes to lethality in acute sepsis: in vivo role for CD40 in innate immunity. Infect Immun 71: 3521-3528.
98. Anand S, Wang P, Yoshimura K, Choi IH, Hilliard A, et al. (2006) Essential role of TNF family molecule LIGHT as a cytokine in the pathogenesis of hepatitis. J Clin Invest 116: 1045-1051.
99. Gartell AL, Tyner AL, (2002) The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 1: 639-649.
100. Choi YL, Park SH, Jang JJ, Park CK, (2001) Expression of the G1-S modulators in hepatitis B virus-related hepatocellular carcinoma and dysplastic nodule: association of cyclin D1 and p53 proteins with the progression of hepatocellular carcinoma. J Korean Med Sci 16: 424-432.
101. Dong C, Li Q, Lyu SC, Krensky AM, Clayberger C, (2005) A novel apoptosis pathway activated by the carboxyl terminus of p21. Blood 105: 1187-1194.
102. Chung HK, Yi YW, Jung NC, Kim D, Suh JM, et al. (2003) CR6-interacting factor 1 interacts with Gadd45 family proteins and modulates the cell cycle. J Biol Chem 278: 28079-28088.
103. Mansuroglu Z, Josse T, Gilleron J, Billecocq A, Leger P, et al. (2010) Nonstructural NSs protein of rift valley fever virus interacts with pericentromeric DNA sequences of the host cell, inducing chromosome cohesion and segregation defects. J Virol 84: 928-939.
104. Anonymous, (2007) Rift Valley fever outbreak-Kenya, November 2006-January 2007. MMWR Morb Mortal Wkly Rep 56: 73-76.
105. Kärber G, (1931) Beitrag zur kollectiven Behandlung pharmakologischer Reihensversuche. Arch Exp Path Pharma 162: 480-483.
106. Pfaffl MW, Horgan GW, Dempfle L, (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30: e36.
107. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.